Turnstone Biologics Corp. - 90042W100

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)
Website: No information yet · Social: No information yet

Company profile

Description is not available for this instrument yet.

Quarter snapshot

Latest / Compare
Q2 2025 · Q1 2025
Value (USD)
Total reported value ($000)
$2.697M
QoQ value delta ($000)
-$109K (-3.88%)
Implied price effect (QoQ)
-12.52%
Shares
Total shares
7,538,843
QoQ shares delta
+677,202 (+9.87%)
Total shares held by funds (by quarter)

Top holders (Q2 2025)

Top 25 only Full list
Early Q3 2025 data: only 1 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
ORBIMED ADVISORS LLC 1,112 3,099,265 0.03%
FMR LLC 407 1,133,987 0.0%
BML Capital Management, LLC 396 1,103,386 0.3%
Point72 Asset Management, L.P. 293 816,923 0.0%
72 Investment Holdings, LLC 197 549,980 0.51%
CITADEL ADVISORS LLC 74 208,887 0.0%
GEODE CAPITAL MANAGEMENT, LLC 46 130,077 0.0%
DELTEC ASSET MANAGEMENT LLC 38 106,057 0.01%
VANGUARD GROUP INC 30 83,926 0.0%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 28 79,305 0.0%
HRT FINANCIAL LP 20 55,859 0.0%
RENAISSANCE TECHNOLOGIES LLC 16 47,100 0.0%
GTS SECURITIES LLC 16 45,163 0.0%
XTX Topco Ltd 13 37,786 0.0%
NORTHERN TRUST CORP 6 18,405 0.0%
ACADIAN ASSET MANAGEMENT LLC 4 16,430 0.0%
Tower Research Capital LLC (TRC) 1 4,741 0.0%
JPMORGAN CHASE & CO 0 158 0.0%
BANK OF AMERICA CORP /DE/ 0 150 0.0%
BNP PARIBAS FINANCIAL MARKETS 0 121 0.0%
UBS Group AG 0 71 0.0%
BlackRock, Inc. 0 1,066 0.0%